Immunization with peptide encapsulated within synthetic spores activates T cell responses and reduces tumor growth

用包裹在合成孢子中的肽进行免疫接种可激活T细胞反应并减少肿瘤生长。

阅读:11
作者:Domenico D'Atri ,Elena Tondini ,Federico Machinandiarena ,Minsuk Kong ,Alilin Mia ,Devorah Gallardo ,Kandice Tanner ,Stephen M Hewitt ,David J Fitzgerald ,Kumaran S Ramamurthi

Abstract

Peptide-based therapeutic immunizations represent safe approaches to elicit antigen-specific T cell responses, but their broad utility remains limited due to poor immunogenicity and short in vivo stability due to rapid degradation and clearance. Here, we employed synthetic bacterial spore-like particles, "SSHELs" (Synthetic Spore Husk-Encased Lipid), made entirely of biocompatible materials, to deliver a model peptide antigen in the absence of additional adjuvants. SSHELs carrying the peptide antigen were internalized by dendritic cells, and SSHEL-delivered peptides were then processed and cross-presented in vitro and in vivo more efficiently than free peptides. Furthermore, SSHEL-delivered peptides elicited effective antigen-specific T cell expansion in a manner that was dependent on particle size and peptide presentation mode (encased peptides were superior to surface-attached peptides). In a mouse melanoma model expressing the antigen ovalbumin, therapeutic immunization reduced tumor size and increased survival. We propose that SSHELs are a self-adjuvanting peptide delivery system that mimics a natural presentation to elicit a robust immune response.IMPORTANCEEffective delivery of antigens to the immune system is essential for activating the adaptive immune system. Synthetic Spore Husk-Encased Lipids (SSHELs) are synthetic bacterial spore-like particles, where the proteinaceous polymerized surface layer of Bacillus subtilis spores is partially reconstituted around a porous silica bead encased in a membrane. The protein surface allows easy covalent modification of the SSHEL surface, and the porous core permits high-capacity cargo loading. Here, we demonstrate that SSHELs act as a self-adjuvanting delivery system that enhances antigen uptake, processing, and MHC-I cross-presentation by dendritic cells. Importantly, we show that both particle size and antigen localization on or within the SSHEL particle profoundly influence the efficiency of T cell priming. These results establish SSHELs as a modular platform for the delivery of peptide antigens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。